CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ascent Pharmahealth Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ascent Pharmahealth Limited
151-153 Clarendon Street
Phone: +61 (0)3 8677 6660p:+61 03 8677 6660 South Melbourne, Victoria  3205  Australia Ticker: APHAPH
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Ascent Pharmahealth Limited is an Australia-based company. The principal activities of the Company include the sale and distribution of generic pharmaceuticals and other health related products in Australia and Asia. The Australian operations comprise the distribution of locally sourced and imported prescription generic and dermatological pharmaceuticals and specialized consumer personal care products to doctors, pharmacists and other healthcare customers. Asian operations comprise the manufacture and importation of pharmaceuticals and related products to supply customers in the Singapore market, including hospitals and pharmacists, and export customers. Its subsidiaries include Genepharm (Australia) Limited, Ascent Pharmahealth Asia Private Limited, Pharmasave Australia Pty Ltd and Genepharm Proprietary Limited. On April 7, 2009, the Company's subsidiary, Ascent Pharmahealth Asia Private Limited acquired 100% interest in Green Cross Pharma Private Limited.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201012/31/2010Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Warren J.Jenkins 9/1/2010 2/7/2007
Chief Executive Officer, Managing Director, Executive Director DennisBastas 12/10/2003 12/10/2003
Chief Financial Officer, Company Secretary Andrew S.Burgess 7/22/2009 1/27/2009
7 additional Officers and Directors records available in full report.

Business Names
Business Name
APH
Genepharm Australasia Limited
Green Cross Pharma Pte Ltd

General Information
Number of Employees: 17 (As of 6/30/2006)
Outstanding Shares: 249,439,547 (As of 3/15/2011)
Shareholders: 1,878
Stock Exchange: ASX
Fax Number: +61 (0)3 8677 6666


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023